- Home
- XGN vs DOUG Comparison
XGN vs DOUG Comparison
Compare XGN & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- DOUG
- Stock Information
- Founded
- XGN 2002
- DOUG 1911
- Country
- XGN United States
- DOUG United States
- Employees
- XGN N/A
- DOUG N/A
- Industry
- XGN Medical Specialities
- DOUG Building operators
- Sector
- XGN Health Care
- DOUG Real Estate
- Exchange
- XGN Nasdaq
- DOUG Nasdaq
- Market Cap
- XGN 138.3M
- DOUG 161.5M
- IPO Year
- XGN 2019
- DOUG N/A
- Fundamental
- Price
- XGN $7.00
- DOUG $2.34
- Analyst Decision
- XGN Strong Buy
- DOUG
- Analyst Count
- XGN 2
- DOUG 0
- Target Price
- XGN $7.50
- DOUG N/A
- AVG Volume (30 Days)
- XGN 237.8K
- DOUG 1.0M
- Earning Date
- XGN 08-04-2025
- DOUG 08-06-2025
- Dividend Yield
- XGN N/A
- DOUG N/A
- EPS Growth
- XGN N/A
- DOUG N/A
- EPS
- XGN N/A
- DOUG N/A
- Revenue
- XGN $56,724,000.00
- DOUG $1,048,791,000.00
- Revenue This Year
- XGN $19.39
- DOUG $17.61
- Revenue Next Year
- XGN $13.27
- DOUG N/A
- P/E Ratio
- XGN N/A
- DOUG N/A
- Revenue Growth
- XGN 1.78
- DOUG 11.36
- 52 Week Low
- XGN $1.71
- DOUG $1.03
- 52 Week High
- XGN $7.95
- DOUG $3.20
- Technical
- Relative Strength Index (RSI)
- XGN 52.23
- DOUG 45.74
- Support Level
- XGN $6.62
- DOUG $2.44
- Resistance Level
- XGN $7.35
- DOUG $3.00
- Average True Range (ATR)
- XGN 0.48
- DOUG 0.15
- MACD
- XGN -0.10
- DOUG -0.07
- Stochastic Oscillator
- XGN 29.63
- DOUG 11.76
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.